SAMHD1: A novel antiviral factor in intrinsic immunity

Future Microbiology

Volumn 7, Issue 9, 2012, Pages 1117-1126

  Chen, Zhangming ^a   Zhang, Linjie ^a   Ying, Songcheng ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

dNTPs; intrinsic immunity; SAMHD1; Vpx

Indexed keywords

COMPLEMENTARY DNA; PROTEIN; PROTEIN SAMHD1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

AICARDI GOUTIERES SYNDROME; BONE MARROW CELL; DENDRITIC CELL; GENE MUTATION; HUMAN; LENTIVIRUS INFECTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; REVIEW; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; DENDRITIC CELLS; HIV-1; HUMANS; MACROPHAGES; MONOMERIC GTP-BINDING PROTEINS; NERVOUS SYSTEM MALFORMATIONS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

LENTIVIRUS; PRIMATES;

EID: 84866094901     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.81     Document Type: Review

References (78)

1. Yan N, Chen ZJ. Intrinsic antiviral immunity. Nat. Immunol. 13(3), 214-222 (2012).
2. Douville RN, Hiscott J. The interface between the innate interferon response and expression of host retroviral restriction factors. Cytokine 52(1-2), 108-115 (2010).
3. Mangeat B, Trono D. Lentiviral vectors and antiretroviral intrinsic immunity. Hum. Gene Ther. 16(8), 913-920 (2005).
4. Bieniasz PD. Intrinsic immunity: A front-line defense against viral attack. Nat. Immunol. 5(11), 1109-1115 (2004).
5. Lu J, Pan Q, Rong L, He W, Liu SL, Liang C. The IFITM proteins inhibit HIV-1 infection. J. Virol. 85(8), 2126-2137 (2011).
6. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427(6977), 848-853 (2004).
7. Nakayama EE, Shioda T. Role of human TRIM5a in intrinsic immunity. Front. Microbiol. 3, 97 (2012).
8. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418(6898), 646-560 (2002).
9. Aguiar RS, Peterlin BM. APOBEC3 proteins and reverse transcription. Virus Res. 134(1-2), 74-85 (2008).
10. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451(7177), 425-430 (2008).
11. Sato K, Gee P, Koyanagi Y. Vpu and BST2: Still not there yet? Front. Microbiol. 3, 131 (2012).
12. Brass AL, Huang IC, Benita Y et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139(7), 1243-1254 (2009).
13. Everitt AR, Clare S, Pertel T et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484(7395), 519-523 (2012).
14. Sasada A, Takaori-Kondo A, Shirakawa K et al. APOBEC3G targets human T-cell leukemia virus type 1. Retrovirology 2, 32 (2005).
15. Turelli P, Mangeat B, Jost S, Vianin S, Trono D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 303(5665), 1829 (2004).
16. Fehrholz M, Kendl S, Prifert C et al. The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses. J. Gen. Virol. 93(Pt 3), 565-576 (2012).
17. Jouvenet N, Neil SJD, Zhadina M et al. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 83(4), 1837-1844 (2009).
18. Sakuma T, Noda T, Urata S, Kawaoka Y, Yasuda J. Inhibition of Lassa and Marburg virus production by tetherin. J. Virol. 83(5), 2382-2385 (2009).
19. Mansouri M, Viswanathan K, Douglas JL et al. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 83(19), 9672-9681 (2009).
20. Ma Y, Yu J, Chan HL, Chen YC et al. Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol. Cell. Proteomics 8(11), 2582-2594 (2009).
21. Adler M, Tavalai N, Müller R, Stamminger T. Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100. J. Gen. Virol. 92(Pt 7), 1532-1538 (2011).
22. Tavalai N, Papior P, Rechter S, Stamminger T. Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J. Virol. 82(1), 126-137 (2008).
23. Wissing S, Galloway NL, Greene WC. HIV-1 Vif versus the APOBEC3 cytidine deaminases: An intracellular duel between pathogen and host restriction factors. Mol. Aspects Med. 31(5), 383-397 (2010).
24. Ayinde D, Maudet C, Transy C, Margottin- Goguet F. Limelight on two HIV/SIV accessory proteins in macrophage infection: Is Vpx overshadowing Vpr? Retrovirology 7, 35 (2010).
25. Fletcher TM 3rd, Brichacek B, Sharova N et al. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/ SIV(SM). EMBO J. 15(22), 6155-6165 (1996).
26. Goujon C, Jarrosson-Wuillème L, Bernaud J, Rigal D, Darlix JL, Cimarelli A. With a little help from a friend: Increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV(MAC). Gene Ther. 13(12), 991-994 (2006).
27. Fujita M, Otsuka M, Miyoshi M, Khamsri B, Nomaguchi M, Adachi A. Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages. J. Virol. 82(15), 7752-7756 (2008).
28. Sharova N, Wu Y, Zhu X et al. Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog. 4(5), e1000057 (2008).
29. Srivastava S, Swanson SK, Manel N, Florens L, Washburn MP, Skowronski J. Lentiviral Vpx accessory factor targets VprBP/ DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog. 4(5), e1000059 (2008).
30. Bergamaschi A, Ayinde D, David A et al. The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. J. Virol. 83(10), 4854-4860 (2009).
31. Sunseri N, O'Brien M, Bhardwaj N, Landau NR. Human immunodeficiency virus type 1 modified to package simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. J. Virol. 85(13), 6263-6274 (2011).
32. Laguette N, Sobhian B, Casartelli N et al. SAMHD1 is the dendritic- and myeloid-cell specific HIV-1 restriction factor counteracted by Vpx. Nature 474(7353), 654-657 (2011).
33. Hrecka K, Hao C, Gierszewska M et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474(7353), 658-661 (2011).
34. Li N, Zhang W, Cao X. Identification of human homologue of mouse IFN-g induced protein from human dendritic cells. Immunol. Lett. 74(3), 221-224 (2000).
35. Qiao F, Bowie JU. The many faces of SAM. Sci. STKE 286, re7 (2005).
36. Kim CA, Bowie JU. SAM domains: Uniform structure, diversity of function. Trends Biochem. Sci. 28(12), 625-628 (2003).
37. Aviv T, Lin Z, Lau S, Rendl LM, Sicheri F, Smibert CA. The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators. Nat. Struct. Biol. 10(8), 614-621 (2003).
38. Aravind L, Koonin EV. The HD domain defines a new superfamily of metal-dependent phosphohydrolases. Trends Biochem. Sci. 23(12), 469-472 (1998).
39. Vorontsov II, Minasov G, Kiryukhina O, Brunzelle JS, Shuvalova L, Anderson WF. Characterization of the deoxynucleotide triphosphate triphosphohydrolase (dNTPase) activity of the EF1143 protein from Enterococcus faecalis and crystal structure of the activator-substrate complex. J. Biol. Chem. 286(38), 33158-33166 (2011).
40. Goldstone DC, Ennis-Adeniran V, Hedden JJ et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480(7377), 379-382 (2011).
41. Powell RD, Holland PJ, Hollis T, Perrino FW. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J. Biol. Chem. 286(51), 43596-43600 (2011).
42. Lahouassa H, Daddacha W, Hofmann H et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13(3), 223-228 (2012).
43. Gao WY, Cara A, Gallo RC, Lori F. Low levels of deoxynucleotides in peripheral blood lymphocytes: A strategy to inhibit human immunodeficiency virus type 1 replication. Proc. Natl Acad. Sci. USA 90(19), 8925-8928 (1993).
44. Diamond TL, Roshal M, Jamburuthugoda VK et al. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J. Biol. Chem. 279(49), 51545-51553 (2004).
45. Kennedy EM, Gavegnano C, Nguyen L et al. Ribonucleoside triphosphates as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophages. J. Biol. Chem. 285(50), 39380-39391 (2010).
46. O'Brien WA, Namazi A, Kalhor H, Mao SH, Zack JA, Chen IS. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68(2), 1258-1263 (1994).
47. Jamburuthugoda VK, Chugh P, Kim B. Modification of human immunodeficiency virus type 1 reverse transcriptase to target cells with elevated cellular dNTP concentrations. J. Biol. Chem. 281(19), 13388-13395 (2006).
48. Kim B, Nguyen LA, Daddacha W, Hollenbaugh JA. Tight interplay among SAMHD1 level, cellular dNTP levels and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages. J. Biol. Chem. 287(26), 21570-21574 (2012) .
49. Ahn J, Hao C, Yan J et al. HIV/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1. J. Biol. Chem. 287(15), 12550-12558 (2012).
50. Laguette N, Rahm N, Sobhian B et al. Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 11(2), 205-217 (2012).
51. Lim ES, Fregoso OI, McCoy CO, Matsen FA, Malik HS, Emerman M. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11(2), 194-204 (2012).
52. Compton AA, Hirsch VM, Emerman M. The host restriction factor APOBEC3G and retroviral Vif protein coevolve due to ongoing genetic conflict. Cell Host Microbe 11(1), 91-98 (2012).
53. Sawyer SL, Wu LI, Emerman M, Malik HS. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl Acad. Sci. USA 102(8), 2832-2837 (2005).
54. Serra-Moreno R, Evans DT. Adaptation of human and simian immunodeficiency viruses for resistance to Tetherin/BST-2. Curr. HIV Res. 10(4), 277-282 (2012).
55. Zhang C, de Silva S, Wang JH, Wu L. Co-evolution of primate SAMHD1 and lentivirus Vpx leads to the loss of the vpx gene in HIV-1 ancestor. PLoS One 7(5), e37477 (2012).
56. Lee-Kirsch MA. Nucleic acid metabolism and systemic autoimmunity revisited. Arthritis Rheum. 62(5), 1208-1212 (2010).
57. Chahwan C, Chahwan R. Aicardi- Goutieres syndrome: From patients to genes and beyond. Clin. Genet. 81(5), 413-420 (2012).
58. Crow YJ, Hayward BE, Parmar R et al. Mutations in the gene encoding the 3́-5́ DNA exonuclease TREX1 cause Aicardi- Goutières syndrome at the AGS1 locus. Nat. Genet. 38(8), 917-920 (2006).
59. Crow YJ, Leitch A, Hayward BE et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat. Genet. 38(8), 910-916 (2006).
60. Rice GI, Bond J, Asipu A et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 41(7), 829-832 (2009).
61. Crow YJ, Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: Linking nucleic acid metabolism with autoimmunity. Hum. Mol. Genet. 18(R2), R130-R136 (2009).
62. Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134(4), 587-598 (2008).
63. Goncalves A, Karayel E, Rice GI et al. SAMHD1 is a nucleic-acid binding protein that is mislocalized due to Aicardi-Goutières syndrome-associated mutations. Hum. Mutat. 33(7), 1116-1122 (2012).
64. Xin B, Jones S, Puffenberger EG et al. Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc. Natl Acad. Sci. USA 108(13), 5372-5377 (2011).
65. du Moulin M, Nürnberg P, Crow YJ, Rutsch F. Cerebral vasculopathy is a common feature in Aicardi-Goutieres syndrome associated with SAMHD1 mutations. Proc. Natl Acad. Sci. USA 108(26), E232 (2011); author reply E233 (2011).
66. Leshinsky-Silver E, Malinger G, Ben-Sira L et al. A large homozygous deletion in the SAMHD1 gene causes atypical Aicardi- Goutiéres syndrome associated with mtDNA deletions. Eur. J. Hum. Genet. 19(3), 287-292 (2011).
67. Berger A, Sommer AF, Zwarg J et al. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection. PLoS Pathog. 7(12), e1002425 (2011).
68. Coon S, Wang D, Wu L. Polymorphisms of the SAMHD1 gene are not associated with the infection and natural control of HIV type 1 in Europeans and African- Americans. AIDS Res. Hum. Retroviruses doi:10.1089/aid.2012.0039 (2012) (Epub ahead of print).
69. Liao W, Bao Z, Cheng C, Mok YK, Wong WS. Dendritic cell-derived interferon-gamma-induced protein mediates tumor necrosis factor-alpha stimulation of human lung fibroblasts. Proteomics 8(13), 2640-2650 (2008).
70. Thiele H, du Moulin M, Barczyk K et al. Cerebral arterial stenoses and stroke: Novel features of Aicardi-Goutières syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expression. Hum. Mutat. 31(11), E1836-E1850 (2010).
71. Hartman ZC, Kiang A, Everett RS et al. Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. J. Virol. 81(4), 1796-1812 (2007).
72. Préhaud C, Mégret F, Lafage M, Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79(20), 12893-12904 (2005).
73. Zhao D, Peng D, Li L, Zhang Q, Zhang C. Inhibition of G1P3 expression found in the differential display study on respiratory syncytial virus infection. Virol. J. 5, 114 (2008).
74. Brandariz-Nuñez A, Valle-Casuso JC, White TE et al. Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac. Retrovirology 9(1), 49 (2012).
75. Belshan M, Mahnke LA, Ratner L. Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex in non-dividing cells. Virology 346(1), 118-126 (2006).
76. Mahalingam S, Van Tine B, Santiago ML, Gao F, Shaw GM, Hahn BH. Functional analysis of the simian immunodeficiency virus Vpx protein: Identification of packaging determinants and a novel nuclear targeting domain. J. Virol. 75(1), 362-374 (2001).
77. Belshan M, Ratner L. Identification of the nuclear localization signal of human immunodeficiency virus type 2 Vpx. Virology 311(1), 7-15 (2003).
78. Cohen D, Adamovich Y, Reuven N, Shaul Y. Hepatitis B virus activates deoxynucleotide synthesis in nondividing hepatocytes by targeting the R2 gene. Hepatology 51(5), 1538-1546 (2010).